Recherche avancée

Actuellement, Helen Giza occupe le poste de directeur financier de Fresenius Medical Care AG & Co. KGaA et de Chief Financial Officer & Member-Management Board chez Fresenius Medical Care Management AG. Elle est également membre du conseil d'administration de Fresenius Medical Care Holdings, Inc. Auparavant, elle a occupé les postes de contrôleur de secteur commercial pour la région Asie-Pacifique chez Abbott Laboratories, de vice-présidente et de contrôleuse de division chez TAP Pharmaceutical Products, Inc. et de comptable analytique chez ITT, Inc. et de responsable en chef de l'intégration et de la gestion des cessions chez Takeda Pharmaceuticals International, Inc. Elle est titulaire d'un MBA de la Kellogg School of Management.

Helen M. Nugent est une femme d'affaires qui a été à la tête de 15 entreprises différentes. Actuellement, elle est présidente de la National Portrait Gallery (Australie), de la National Disability Insurance Agency et du Veda Group Pty Ltd. Elle est également présidente de la Cranbrook School, présidente de la National Opera Review du gouvernement australien, chancelière de la Bond University et membre du conseil d'administration de cinq autres entreprises. Dans le passé, Mme Nugent a occupé les postes de présidente de l'aéroport de Sydney, présidente du Conseil australien des arts, directrice de la stratégie de la Westpac Banking Corp, présidente de l'enquête sur les grands arts du spectacle du groupe australien des grands arts du spectacle, présidente de la Superannuation Funds Management Corp. d'Australie-Méridionale, présidente non exécutive d'Ausgrid Pty Ltd. et présidente du conseil d'administration d'Equeda Group Pty Ltd, Président non exécutif indépendant de Equifax Pty Ltd, Président de The Mercantile & General Reinsurance Co. of Australia Ltd, Président non exécutif indépendant de Equifax Australia Group Pty Ltd, Président de Hudson Global Resources (Aust) Pty Ltd, Président de Australian Rail Track Corp. Ltd, président de Hudson Global Resources (NZ) Ltd, président de Swiss Re Australia Ltd, membre de l'Australian Higher Education Review au ministère australien de l'Éducation et de la Formation, associé chez Mckinsey & Co, professeur à l'Université de New South Wales et professeur à l'Australian Graduate School of Management. Helen M. Nugent est titulaire d'un doctorat et d'un diplôme de premier cycle de l'Université du Queensland et d'un MBA de l'Université de Harvard.

Mme Helen L. Shan est directrice indépendante d'EPAM Systems, Inc. et directrice des finances et des revenus de FactSet Research Systems, Inc. Elle est membre du conseil d'administration d'EPAM Systems, Inc. et de FactSet Europe Ltd. et de Vermilion Holdings Ltd. Auparavant, Mme Shan a été employée en tant que directrice financière chez Mercer Consulting Group, Inc, trésorière et vice-présidente chez Marsh & McLennan Cos, Inc, trésorière et vice-présidente chez Pitney Bowes, Inc, directrice générale des industries diversifiées chez JPMorgan Securities LLC et contrôleur chez Salomon Brothers. Elle a obtenu un diplôme de premier cycle à la Wharton School de l'université de Pennsylvanie, un diplôme de premier cycle à la School of Engineering & Applied Science et un MBA à la Johnson Graduate School of Management.

Helen Lofthouse is currently the CEO, Managing Director & Executive Director at ASX Ltd.
She also holds director positions at ASX Clearing Corp.
Ltd., ASX Clear (Futures) Pty Ltd., ASX Clear Pty Ltd., ASX Settlement Corp.
Ltd., ASX Settlement Pty Ltd., and Austraclear Ltd.
Previously, she worked as a Managing Director at UBS Group AG from 2011 to 2015.

Helen I. Torley occupe le poste de présidente, directrice générale et directrice chez Halozyme Therapeutics, Inc. Elle est également membre du conseil d'administration de Quest Diagnostics, Inc., directrice et membre du conseil d'administration de la section santé de la Biotechnology Innovation Organization et membre du Royal College of Physicians. Dans le passé, elle a été vice-présidente et directrice générale de la santé osseuse aux États-Unis chez Amgen, Inc. et directrice commerciale et vice-présidente exécutive d'Onyx Pharmaceuticals, Inc. (une filiale d'Amgen, Inc.), vice-présidente des affaires médicales de Novartis, Inc. et vice-présidente des affaires médicales de Sandoz SA, ainsi que vice-présidente des ventes de produits cardiovasculaires et métaboliques du Bristol-Myers Squibb World Wide Medicines Group. Elle a obtenu un diplôme de premier cycle à l'université de Glasgow.

Helen Jane Ashton is the founder of Fire Bright Solutions Ltd., which was founded in 2003.
She is currently an Independent Non-Executive Director at JD Sports Fashion Plc, Director at JLA Total Care Ltd., Director at Direct Catering Products Ltd., Director at Astral Fire & Security Ltd., Director at Atlas Sterile Services Ltd., Director at Atlas Services Holdings Ltd., and Director at T Jolly Facility Services Ltd.
Ms. Ashton's former positions include Chief Executive Officer & Director at Vanilla Group Ltd., Chief Executive Officer at Capquest Group Ltd., Chief Executive Officer at JLA Ltd., Director at JLA EquityCO Ltd.
from 2019 to 2020, Chief Financial Officer at ASOS Plc in 2018, and Chief Operating Officer at Arrow Global Group Ltd.
She obtained an undergraduate degree from The University of Manchester.

Helen Miles is currently the Chief Financial Officer & Executive Director at Severn Trent Plc since 2014.
She is also an Independent Non-Executive Director at Breedon Group Plc since 2021.
Additionally, she holds a position as a Non-Executive Director at the Royal Navy.
Previously, she worked as a Director at Hafren Dyfrdwy Cyfyngedig, Chief Financial Officer at Corente, Inc., and Chief Financial Officer at Openreach Ltd.

Helen McCabe currently works at Rolls-Royce Holdings Plc, as Chief Financial Officer & Director from 2023, Rolls-Royce Group Ltd., as Director from 2023, and Rolls-Royce Plc, as Chief Financial Officer from 2023.

Helen Marie Boudreau is currently an Independent Director at CARA Therapeutics, Inc., Premier, Inc., Shattuck Labs, Inc., Rallybio LLC, Field Trip Health, Inc., Field Trip Psychedelics, Inc., Rallybio Corp., and Managing Director at Estuary Ventures LLC.
Previously, she held positions as Director-Strategic Planning at Yum!.
Brands, Inc., Independent Director at Evaxion Biotech A, Independent Director at Field Trip Health Ltd., Independent Director at Reunion Neuroscience, Inc., Principal at Bank of America Corp., Vice President-Finance, Research & Development at Pfizer Inc., Chief Financial Officer & VP-Investor Relations at Novartis Oncology, Inc., Chief Financial Officer at Novartis Corp., Chief Financial Officer at Forma Therapeutics, Inc., Engagement Manager at McKinsey & Co., Inc., Treasurer, Chief Financial & Accounting Officer at Proteostasis Therapeutics, Inc., and Chief Operating Officer at Bill & Melinda Gates Medical Research Institute.
She obtained an MBA from the University of Virginia Darden School of Business in 1993.

Actuellement, Helen W. Crossen occupe le poste de directeur administratif d'Annaly Capital Management, Inc. Dans le passé, Mme Crossen a occupé le poste de vice-présidente des ressources humaines de NBC Universal, Inc. Mme Crossen a obtenu un diplôme de premier cycle et un diplôme d'études supérieures de la Rutgers State University of New Jersey.

Helen Anne Coonan est une femme d'affaires qui a été à la tête de 9 entreprises différentes. Elle occupe le poste de présidente exécutive de Crown Resorts Ltd, présidente de Sydney Harbour Foreshore Authority, présidente de Supervised Investments Australia Ltd, présidente de Crown Resorts Foundation Ltd, présidente d'Australian Financial Complaints Authority Ltd et coprésidente de GRACosway. Helen Anne Coonan est également présidente du Minerals Council of Australia, membre du conseil d'entreprise du European Australian Business Council, membre de Chief Executive Women, Inc. et membre du conseil d'administration de six autres sociétés. Elle a précédemment occupé les postes de présidente non exécutive de HGL Ltd, d'associée de Gadens Lawyers (Australie), de ministre des communications du Parlement australien et de coprésidente de Government Relations Australia Advisory Ltd. Mme Coonan a obtenu un diplôme de premier cycle et un diplôme d'études supérieures de l'Université de Sydney.

Fondatrice de Next Generation Now, Inc, Helen P. Johnson-Leipold est une femme d'affaires qui a été à la tête de 8 entreprises différentes et qui occupe actuellement le poste de président-directeur général de Johnson Outdoors, Inc, président de Johnson Keland Management, Inc, président de Johnson Financial Group, Inc et président de Johnson Bank (Wisconsin). Elle est également membre du conseil d'administration de S.C. Johnson & Son, Inc. et de Commercial Markets Holdco, Inc. et de The Prairie School, Inc. et présidente du conseil d'administration de The Johnson Foundation at Wingspread. Auparavant, elle a été présidente de Diversey, Inc, présidente de Next Generation Now, Inc, présidente de Diversey Holdings LLC et directrice de Foote, Cone & Belding Worldwide. Elle est titulaire d'un diplôme de premier cycle de l'université Cornell.

Siv Helen Rygh Torstensen est Senior VP-Legal & Group General Counsel chez Equinor ASA. Mme Torstensen a obtenu un diplôme d'études supérieures de l'Université de Bergen.

Elena Giza has worked as a Director at Comet SA since 2013.

Helen Maye worked as the Chief Human Resources Officer at Smith & Nephew plc.

Helen Robinson currently works at New Zealand Business Excellence Foundation, as Director and Baptistcare WA Ltd., as Director.
Ms. Robinson also formerly worked at Microsoft New Zealand Ltd., as Chief Executive Officer, Rex Bionics Ltd., as Chief Executive Officer, MarkIT Holding AS, as Managing Director-Environmental Markets, TZ1 Registry, as Managing Director-Global Environmental Markets in 2010, National Institute of Water & Atmospheric Research Ltd., as Director, Pivotal Corp., as Vice President-APAC, and Anesthesiologists Professional Assurance Co., as Vice President.

Helen Young is a member of several professional organizations, including The Chartered Governance Institute, Hong Kong Institute of Certified Public Accountants, The Hong Kong Institute of Chartered Secretaries, and Association of Chartered Certified Accountants (Hong Kong).
She previously worked as a Joint Secretary at Kaisun Holdings Ltd.
from 2010 to 2021.
She holds an MBA from the University of Hong Kong.
Currently, she holds multiple positions, including Member at The Chartered Governance Institute, Hong Kong Institute of Certified Public Accountants, The Hong Kong Institute of Chartered Secretaries, and Association of Chartered Certified Accountants (Hong Kong).

Helen Benz worked as a Chief Financial Officer at American Cleaning Institute.

Helen Ye worked as an Analyst at JPMorgan Securities (Asia Pacific) Ltd.
from 2011 to 2013.

Helen Guishard is a Member of the Institute of Chartered Accountants in England & Wales and the Institute of Chartered Accountants of Bermuda, where she currently holds positions.
She previously worked as a Financial Controller at American Overseas Group Ltd.
Ms. Guishard obtained an undergraduate degree from the University of Birmingham.

Helen Ellis Grosvenor worked at Mr. Price Group Ltd.
from 2003 to 2017.
She held the position of Secretary from 2012 to 2017.

Helen Zell is currently the Director at Ounce of Prevention Fund.
She previously served as a Trustee at The Museum of Contemporary Art (Illinois).

Helen T.
Kerr is a trustee at The University of Tampa, Inc.

Helen Margaret Page is currently the Director at Virgin Money Giving Ltd.
She also holds the position of Independent Non-Executive Director at The Artisanal Spirits Co. Plc.
In addition, she serves as a Trustee at the Scottish Society for the Prevention of Cruelty to Animals and Scotland's Charity Air Ambulance.
Previously, Ms. Page worked as the Managing Director-Marketing & Innovation at NatWest Group Plc in 2012.
She also held the position of Director-Customer Proposition at Yorkshire Bank Plc.
From 2004 to 2011, she was the Managing Director-Marketing at Direct Line Insurance Ltd.
She then became the Group Director-Innovation & Marketing at Virgin Money UK Plc from 2012 to 2021.
Additionally, she worked as the Managing Director-Marketing & Innovation at The Royal Bank of Scotland Plc.
Prior to that, she was the Head-Brand Marketing at Argos Ltd.
from 2002 to 2004 and the Head-Marketing at The Abbey Group UK Ltd.

Dr. Helen Haworth, CFA, is Managing Director at Credit Suisse Securities (Europe) Ltd.
Dr. Haworth is Head of Global Interest Rate Research and European ABS Research.
She joined Credit Suisse in 2007.
Previously, she was a Senior Credit Analyst in the Fixed Income Team at HSBC Asset Management Canada.
Dr. Haworth holds an MMath in Mathematics from Oxford University and is a CFA charterholder.
She did postdoctoral research in credit modelling at Oxford University, having graduated with a DPhil in Financial Mathematics from Oxford in 2006.

Helen Mix has held the following positions in her career:- Vice President-People at Boardwalk Real Estate Investment Trust since 1999.
-.
Vice President-Human Resources at Boardwalk Real Estate Management Ltd.
since 2004.

Helen Evans is currently working as Co-Deputy Chairman at The Fred Hollows Foundation (UK), Director at Global Funds Management Australia Ltd., and Director at The Macfarlane Burnet Institute For Medical Research & Public.
Previously, she worked as Chief Executive Officer at GAVI Alliance.

Helen Jane Gillies is currently a Non-Executive Director at BAC Holdings Ltd., Monadelphous Group Ltd., Bankstown Airport Pty Ltd., Camden Airport Pty Ltd., and Lexon Insurance Pte Ltd.
She is also a Member of the Australian Institute of Co. Directors.
In the past, she served as an Independent Non-Executive Director at Aurelia Metals Ltd.
and Yancoal Australia Ltd.
She was also a Director & Corporate Counsel at Jacobs Group (Australia) Pty Ltd., Director at Civil Aviation Safety Authority, Director, General Counsel & General Manager-Risk at Sinclair Knight Merz Management Pty Ltd., Non-Executive Director at The Red Flag Group Ltd., and Director at Red Flag Group Holdings Ltd.
Ms. Gillies holds a graduate degree from the University of Melbourne, undergraduate and graduate degrees from The University of Queensland, and an MBA from The University of Sydney.

Helen Lau is currently working as an Analyst at CCB International Securities Ltd.
She previously worked as an Analyst at UOB Kay Hian (Hong Kong) Ltd., Everbright Securities Global (HK) Ltd., and Research Analyst at ZTF Securities Co. Ltd.
From 2015 to 2020, she worked as an Analyst at Argonaut Securities (Asia) Ltd.

Helen Wanjiru Gichohi is an Independent Non-Executive Director at Bamburi Cement Co. Ltd.
and Equity Group Holdings Plc.
She is also a Director at OL Pejeta Conservancy and a Trustee at African Wildlife Foundation, Inc. Previously, she held positions as the Managing Director at Wildlife Conservation Society, Director at Equity Bank (Kenya) Ltd., and Director at Kenya Wildlife Service.
She also served as the Managing Director at Equity Group Foundation from 2012 to 2017 and as the Managing Director at African Conservation Centre.
Dr. Gichohi holds a doctorate degree from the University of Leicester, a graduate degree from the University of Nairobi, and an undergraduate degree from Kenyatta University.

Helen Shik is currently working as Vice President at Schwartz Communications, Inc. since 1996.
She completed her undergraduate degree from Boston University in 1987.

Ms. Helen Wen is an Analyst at ICBC International Research Ltd.
Ms. Wen was previously employed as a Research Analyst by Morgan Stanley Asia Ltd.
and Morgan Stanley Dean Witter Asia Ltd.

Ms. Helen Cameron is Interim Managing Director & Non-Executive Director at CBio Ltd.
She is on the Board of Directors at CBio Ltd.
Ms. Cameron was previously employed as a Research Analyst by Citigroup Global Markets Australia Pty Ltd.

Helen serves as Director of Ventures at Ufi, working with early-stage technology companies focused on the future of work and skills and sits on the board of Learnerbly, Learning Labs and Data Literacy Academy.
Helen has been investing in early-stage ventures since 2002 and early-stage impact ventures since 2016.
Helen was previously Investment Director at Nesta Impact Investments, where she led several investments in high-growth businesses (Applied, Third Space Learning and Oomph) and managed successful exits for the fund (Applied and Reconnections).

Helen Dwyer currently works at Alumni Association of the University of Virginia, as Director-Operations & Business Planning.

Helen Joanna Brand currently works at Association of Chartered Certified Accountants, as Chief Executive Officer, The Chartered Certified Accountant's Benevolent Fund, as Chief Executive Officer from 2008, The Value Reporting Foundation, as Vice Chairman, Certified Accountants Investment Co. Ltd., as Director from 2017, and Certified Accountant (Publications) Ltd., as Director.

Helen Neville is Head of Marketing for SeQuential Biofuels LLC.
Most recently, she was Director of Marketing for Pharmaca Integrative Pharmacy.
Previously, she was a Consultant for IBM and Healthnotes.
Earlier, she worked for HEB Grocery Co. Ms. Neville has 13 years of retail marketing and management experience.
She received a Bachelor's degree in English from the University of Texas in 1992 and an MBA from the University of Colarado in 2001.

Helen Benedict worked as a Marketing Director at PizzaExpress Ltd.